Whalesbook
India Leads Growth Amid Global Slowdown
Reckitt Benckiser's strong performance in India is a key growth driver, but it contrasts with a challenging global economic climate. This difference between regional success and slower group growth shows the balance Reckitt needs to maintain amidst changing consumer habits and ongoing geopolitical issues.
India's Strong Quarter vs. Group Performance
India operations achieved double-digit revenue growth in Q1 FY2026, driven by brands like Dettol, Durex, and Finish. CEO Kris Licht attributed this to wider distribution from sales improvements, benefiting brands such as Harpic and Lizol. This strong regional showing contrasted with the group's overall like-for-like net revenue growth of just 0.6%. Excluding a mild cold and flu season, Reckitt's core business grew 3.1%, largely due to emerging markets like India and China posting double-digit gains. Despite India's success, the company's shares dropped 5.6% to around 4,644.00 pence on the news.
Global Challenges Offset India's Success
The results showed a split performance for Reckitt. Emerging markets like India and China remain key growth areas, but Europe and North America faced difficulties. Europe's like-for-like revenue fell 4.2% due to weak category sales and competitive pricing, especially in auto-dishwashing. North America saw a 0.9% drop, though its non-seasonal products like Lysol grew in the mid-single digits. In India, the consumer staples market is expected to grow 6-8% in FY2026, with a trend towards volume growth supported by recovering urban demand and resilient rural consumption. Reckitt's India performance aligns with or exceeds this trend. Globally, commodity prices are a concern. While some predict lower prices for 2026, Middle East conflict has pushed oil prices up, potentially impacting consumer spending. Around 40% of Reckitt's raw materials are linked to oil prices. The company faced similar first-quarter challenges in April 2025 due to lower volumes, indicating a recurring issue.
Risks and Financial Concerns
Despite India's success, Reckitt faces structural issues and economic risks. The overall group growth of 0.6% in Q1 FY2026 is weak compared to the promising Indian FMCG market. Relying on emerging markets brings currency and geopolitical risks, including issues from Russia and the Middle East. Financial indicators like a current ratio of 0.85 and a debt-to-equity ratio of 108.83% suggest potential liquidity concerns. The stock has been near its 52-week low and fell after the Q1 report. Analysts generally rate the stock a 'Hold' with an average price target of GBX 6,219.86, but some recent price target cuts and market uncertainty temper this. Reckitt's past acquisition of Mead Johnson also presented difficulties, leading to divestments and legal issues that have affected growth.
Company Reaffirms Outlook
Reckitt Benckiser has reaffirmed its full-year guidance for core LFL net revenue growth of 4% to 5%. The company expects better performance from the second quarter onward, anticipating a normal cold and flu season, new product launches (like Mucinex 12-hour Cold and Fever), stronger execution in Europe, and continued growth in China and India. Management expects profit margins to improve in the second half of the year as cost-saving measures counter expenses from sold businesses. Analysts offer a mixed view, with price targets indicating potential gains, but the overall consensus remains 'Hold'. Reckitt is also continuing its £1 billion share buyback, having completed £669 million by mid-April 2026.